BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2428556)

  • 1. Ribonucleic acid turnover in man:RNA catabolites in urine as measure for the metabolism of each of the three major species of RNA.
    Sander G; Topp H; Heller-Schöch G; Wieland J; Schöch G
    Clin Sci (Lond); 1986 Oct; 71(4):367-74. PubMed ID: 2428556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein and RNA turnover in preterm infants and adults: a comparison based on urinary excretion of 3-methylhistidine and of modified one-way RNA catabolites.
    Sander G; Hülsemann J; Topp H; Heller-Schöch G; Schöch G
    Ann Nutr Metab; 1986; 30(2):137-42. PubMed ID: 2421633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of 7-methylguanine, N2,N2-dimethylguanosine, and pseudouridine in ultrafiltrated serum of healthy adults by high-performance liquid chromatography.
    Topp H; Sander G; Heller-Schöch G; Schöch G
    Anal Biochem; 1987 Feb; 161(1):49-56. PubMed ID: 2437827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible use of urinary modified RNA metabolites in the measurement of RNA turnover in the human body.
    Sander G; Topp H; Wieland J; Heller-Schöch G; Schöch G
    Hum Nutr Clin Nutr; 1986 Mar; 40(2):103-18. PubMed ID: 2420752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diurnal variation in the renal excretion of modified RNA catabolites in humans.
    Topp H; Unverzagt S; Rudloff S; Schöch G; Manz F; Fusch C
    Clin Sci (Lond); 2003 Aug; 105(2):195-202. PubMed ID: 12708967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer.
    Waalkes TP; Gehrke CW; Zumwalt RW; Chang SY; Lakings DB; Tormey DC; Ahmann DL; Moertel CG
    Cancer; 1975 Aug; 36(2):390-8. PubMed ID: 1157009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS.
    Nakano K; Nakao T; Schram KH; Hammargren WM; McClure TD; Katz M; Petersen E
    Clin Chim Acta; 1993 Sep; 218(2):169-83. PubMed ID: 7508341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrelation between whole-body turnover rates of RNA and protein.
    Schöch G; Topp H; Held A; Heller-Schöch G; Ballauff A; Manz F; Sander G
    Eur J Clin Nutr; 1990 Sep; 44(9):647-58. PubMed ID: 1702054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between urinary excretion of modified nucleosides and rheumatoid arthritis process.
    Tebib JG; Reynaud C; Cedoz JP; Letroublon MC; Niveleau A
    Br J Rheumatol; 1997 Sep; 36(9):990-5. PubMed ID: 9376997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Composition, associated tissue methyltransferase activity, and catabolic end products of transfer RNA from carcinogen-induced hepatoma and normal monkey livers.
    Lakings DB; Waalkes TP; Borek E; Gehrke CW; Mrochek JE; Longmore J; Adamson RH
    Cancer Res; 1977 Jan; 37(1):285-92. PubMed ID: 187335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of proton NMR spectroscopy to measurement of whole-body RNA degradation rates: effects of surgical stress in human patients.
    Marway JS; Anderson GJ; Miell JP; Ross R; Grimble GK; Bonner AB; Gibbons WA; Peters TJ; Preedy VR
    Clin Chim Acta; 1996 Aug; 252(2):123-35. PubMed ID: 8853560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Excretion of normal and modified RNA catabolites and creatinine in the urine as a function of nutrition in children].
    Schöch G; Heller-Schöch G; Müller J; Clemens P; Holtgrewe A; Heddrich M
    Monatsschr Kinderheilkd; 1983 May; 131(5):259-63. PubMed ID: 6192333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The degradation rates of cytoplasmic tRNA, rRNA and mRNA in rats are elevated after infection with Nippostrongylus brasiliensis.
    Topp H; Duden R; Stephan U; Schöch G
    Parasitology; 1998 Feb; 116 ( Pt 2)():197-201. PubMed ID: 9509030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative base-resolution sequencing technology for mapping pseudouridines in mammalian mRNA.
    Zhang LS; Dai Q; He C
    Methods Enzymol; 2023; 692():23-38. PubMed ID: 37925181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive markers of oxidative DNA stress, RNA degradation and protein degradation are differentially correlated with resting metabolic rate and energy intake in children and adolescents.
    Topp H; Fusch G; Schöch G; Fusch C
    Pediatr Res; 2008 Sep; 64(3):246-50. PubMed ID: 18437098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudouridine in RNA: what, where, how, and why.
    Charette M; Gray MW
    IUBMB Life; 2000 May; 49(5):341-51. PubMed ID: 10902565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major identity determinants for enzymatic formation of ribothymidine and pseudouridine in the T psi-loop of yeast tRNAs.
    Becker HF; Motorin Y; Sissler M; Florentz C; Grosjean H
    J Mol Biol; 1997 Dec; 274(4):505-18. PubMed ID: 9417931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytic techniques in the separation and identification of specific purine and pyrimidine degradation products of tRNA: application to urine samples from cancer patients.
    Mrochek JE; Dinsmore SR; Waalkes TP
    J Natl Cancer Inst; 1974 Dec; 53(6):1553-63. PubMed ID: 4474409
    [No Abstract]   [Full Text] [Related]  

  • 19. Pseudouridine in mRNA: Incorporation, Detection, and Recoding.
    Wu G; Huang C; Yu YT
    Methods Enzymol; 2015; 560():187-217. PubMed ID: 26253972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interrelationship of pseudouridine and transfer RNA metabolic disorders in thermal injury].
    Salomatin VV; Efimenko GP; Kamilov FKh; Lifshits RI
    Vopr Med Khim; 1977; 23(5):642-6. PubMed ID: 595499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.